Cargando…
Plasma Concentrations of Gut Hormones Acyl Ghrelin and Peptide YY and Subsequent Risk of Colorectal Cancer and Molecular Tumor Subtypes
Obesity and metabolic dysfunction are implicated in colorectal cancer development. Appetite-regulating gut hormones might have a role in colorectal cancer risk. We investigated whether circulating levels of the gut hormones ghrelin (analyzed as acyl ghrelin) and Peptide YY (PYY) were associated with...
Autores principales: | Bodén, Stina, Harbs, Justin, Sundkvist, Anneli, Fuchs, Klara, Myte, Robin, Gylling, Björn, Zingmark, Carl, Löfgren Burström, Anna, Palmqvist, Richard, Harlid, Sophia, Van Guelpen, Bethany |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900320/ https://www.ncbi.nlm.nih.gov/pubmed/36367526 http://dx.doi.org/10.1158/1940-6207.CAPR-22-0325 |
Ejemplares similares
-
A longitudinal study of prediagnostic metabolic biomarkers and the risk of molecular subtypes of colorectal cancer
por: Myte, Robin, et al.
Publicado: (2020) -
Plasma ghrelin is probably not a useful biomarker for risk prediction or early detection of colorectal cancer
por: Sundkvist, Anneli, et al.
Publicado: (2019) -
Targeted plasma proteomics identifies a novel, robust association between cornulin and Swedish moist snuff
por: Sundkvist, Anneli, et al.
Publicado: (2018) -
Circulating levels of inflammatory markers and DNA methylation, an analysis of repeated samples from a population based cohort
por: Myte, Robin, et al.
Publicado: (2019) -
A two-tiered targeted proteomics approach to identify pre-diagnostic biomarkers of colorectal cancer risk
por: Harlid, Sophia, et al.
Publicado: (2021)